Zacks Research Has Optimistic Outlook of Nutrien Q2 Earnings

Nutrien Ltd. (TSE:NTR) – Analysts at Zacks Research upped their Q2 2026 earnings per share estimates for shares of Nutrien in a research report issued on Tuesday, May 19th. Zacks Research analyst Team now forecasts that the company will earn $3.36 per share for the quarter, up from their prior forecast of $3.27. The consensus estimate for Nutrien’s current full-year earnings is $5.34 per share. Zacks Research also issued estimates for Nutrien’s Q3 2026 earnings at $1.24 EPS, Q4 2026 earnings at $1.24 EPS, FY2026 earnings at $6.30 EPS, Q1 2027 earnings at $0.83 EPS, Q2 2027 earnings at $1.69 EPS, Q3 2027 earnings at $1.15 EPS, Q4 2027 earnings at $1.32 EPS, FY2027 earnings at $4.98 EPS, Q1 2028 earnings at $1.04 EPS and FY2028 earnings at $5.56 EPS.

Nutrien (TSE:NTR) last issued its quarterly earnings data on Wednesday, May 6th. The company reported C$0.71 earnings per share (EPS) for the quarter. The firm had revenue of C$8.41 billion during the quarter. Nutrien had a return on equity of 9.49% and a net margin of 8.61%.

A number of other equities research analysts have also commented on NTR. Raymond James Financial raised shares of Nutrien from a “hold” rating to a “moderate buy” rating in a report on Tuesday, May 5th. Wells Fargo & Company raised shares of Nutrien from a “hold” rating to a “strong-buy” rating in a research note on Friday, March 13th. BNP Paribas Exane cut shares of Nutrien from a “strong-buy” rating to a “hold” rating in a research note on Monday, February 23rd. TD Securities raised their price target on shares of Nutrien from C$72.00 to C$80.00 and gave the company a “buy” rating in a report on Wednesday, February 18th. Finally, Barclays upgraded shares of Nutrien from a “hold” rating to a “strong-buy” rating in a research report on Monday, April 27th. Three equities research analysts have rated the stock with a Strong Buy rating, two have given a Buy rating, two have assigned a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat.com, Nutrien presently has an average rating of “Moderate Buy” and an average target price of C$80.00.

Nutrien Stock Performance

Shares of TSE:NTR opened at C$96.82 on Friday. The business has a fifty day moving average of C$101.98 and a 200-day moving average of C$93.62. The company has a debt-to-equity ratio of 55.44, a quick ratio of 0.65 and a current ratio of 1.24. Nutrien has a twelve month low of C$74.77 and a twelve month high of C$116.95. The firm has a market cap of C$46.48 billion, a PE ratio of 19.72, a price-to-earnings-growth ratio of 1.15 and a beta of 1.12.

Insider Buying and Selling at Nutrien

In other Nutrien news, Director Kenneth Alvin Seitz acquired 3,900 shares of the stock in a transaction dated Friday, May 8th. The shares were bought at an average cost of C$94.52 per share, for a total transaction of C$368,628.00. Following the completion of the acquisition, the director directly owned 47,513 shares of the company’s stock, valued at approximately C$4,490,928.76. This trade represents a 8.94% increase in their ownership of the stock. Also, insider Christopher Reynolds bought 2,400 shares of the company’s stock in a transaction that occurred on Friday, May 8th. The shares were bought at an average price of C$95.19 per share, for a total transaction of C$228,456.00. Following the acquisition, the insider directly owned 10,585 shares of the company’s stock, valued at C$1,007,586.15. This represents a 29.32% increase in their position. Over the last quarter, insiders have purchased 7,300 shares of company stock valued at $690,504. 0.03% of the stock is currently owned by corporate insiders.

Trending Headlines about Nutrien

Here are the key news stories impacting Nutrien this week:

• Positive Sentiment: Zacks Research lifted Nutrien’s FY2026 EPS estimate to $6.30 from $6.07, signaling stronger expected full-year profitability.
• Positive Sentiment: The firm raised Q2 2026 EPS to $3.36 from $3.27 and Q3 2026 EPS to $1.24 from $1.03, suggesting improved near-term earnings momentum.
• Positive Sentiment: Zacks Research also increased its Q4 2026 estimate to $1.24 from $1.11 and Q4 2027 estimate to $1.32 from $1.12, reinforcing a more upbeat longer-range outlook.
• Positive Sentiment: Q1 2028 EPS was raised to $1.04 from $0.87, which may help support investor confidence in Nutrien’s earnings trajectory. Article Title
• Neutral Sentiment: Analysts still expect FY2027 EPS of $4.98 and FY2028 EPS of $5.56, both below the FY2026 forecast, indicating some moderation in growth later on.
• Negative Sentiment: Zacks trimmed FY2027 EPS to $4.98 from $5.91 and Q3 2027 EPS to $1.15 from $1.28, showing some caution around future profitability.

Nutrien Company Profile

Nutrien is a leading global provider of crop inputs and services. We operate a world-class network of production, distribution and ag retail facilities that positions us to efficiently serve the needs of growers. We focus on creating long-term value by prioritizing investments that strengthen the advantages of our business across the ag value chain and by maintaining access to the resources and the relationships with stakeholders needed to achieve our goals.